Boston Scientific Corporation
Boston Scientific Amends Corporate Charter at 2026 Annual Meeting
Summary
On April 30, 2026, Boston Scientific Corporation's stockholders approved significant amendments to the Company's Third Restated Certificate of Incorporation at the 2026 Annual Meeting. The amendments, which became effective on May 5, 2026, eliminate supermajority voting provisions and implement other clarifying and correcting changes. Additionally, the stockholders approved the exculpation of certain officers as permitted by Delaware law. These changes were part of the Company's efforts to modernize its corporate governance structure.
Profitelligence Alerts
Get alerts for BSX
Be first to know when Boston Scientific Corporation files with the SEC.
Filing Categories
Advertisement
About Boston Scientific Corporation
Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.
Official SEC Documents
Advertisement